Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 155.14% | 67.79% | -16.39% | 175.61% | -98.48% |
| Total Depreciation and Amortization | -41.30% | -35.53% | -31.71% | -24.72% | -5.78% |
| Total Amortization of Deferred Charges | -5.45% | 5.98% | 251.18% | 162.42% | 85.37% |
| Total Other Non-Cash Items | -177.30% | -90.92% | 5.25% | -231.70% | 14.16% |
| Change in Net Operating Assets | 678.37% | 15,075.91% | 421.99% | 185.72% | 120.48% |
| Cash from Operations | 1,008.79% | 2,206.69% | 2,723.92% | -283.09% | -36.39% |
| Capital Expenditure | -855.58% | -684.28% | -3,768.55% | -177.24% | -146.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.50% | -15,239.39% | 100.00% | -6,526.32% | -671.43% |
| Cash from Investing | -849.11% | -714.21% | -3,656.53% | -192.33% | -1,320.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 95.23% | 99.79% | -106.56% | 74.13% | 25.45% |
| Issuance of Common Stock | 73.79% | -27.81% | -0.82% | -99.52% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.65% | -102.92% | -109.15% | -107.72% | 3,369.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.36% | -181.62% | -583.59% | -410.22% | 10,014.08% |